S. Levie

Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo

S. H. van der Burg, M. A. Gillissen, A. Bakker, 2020, Cancer Immunology, Immunotherapy.

Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice.

M. A. Gillissen, A. Bakker, H. Spits, 2017, Blood advances.

The modified FACS calcein AM retention assay: A high throughput flow cytometer based method to measure cytotoxicity.

M. A. Gillissen, H. Spits, G. de Jong, 2016, Journal of immunological methods.

AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses

M. A. Gillissen, A. Bakker, H. Spits, 2016, Bone Marrow Transplantation.

AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses.

M. A. Gillissen, A. Bakker, H. Spits, 2018, Blood.